Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,039 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis.
Blencowe H, Krasevec J, de Onis M, Black RE, An X, Stevens GA, Borghi E, Hayashi C, Estevez D, Cegolon L, Shiekh S, Ponce Hardy V, Lawn JE, Cousens S. Blencowe H, et al. Among authors: an x. Lancet Glob Health. 2019 Jul;7(7):e849-e860. doi: 10.1016/S2214-109X(18)30565-5. Epub 2019 May 15. Lancet Glob Health. 2019. PMID: 31103470 Free PMC article.
Multisector intervention to accelerate reductions in child stunting: an observational study from 9 sub-Saharan African countries.
Remans R, Pronyk PM, Fanzo JC, Chen J, Palm CA, Nemser B, Muniz M, Radunsky A, Abay AH, Coulibaly M, Mensah-Homiah J, Wagah M, An X, Mwaura C, Quintana E, Somers MA, Sanchez PA, Sachs SE, McArthur JW, Sachs JD; Millennium Villages Study Group. Remans R, et al. Among authors: an x. Am J Clin Nutr. 2011 Dec;94(6):1632-42. doi: 10.3945/ajcn.111.020099. Epub 2011 Oct 26. Am J Clin Nutr. 2011. PMID: 22030229 Free article.
Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-The Phase III MECCA Trial.
Hong RX, Xu F, Xia W, Teng YE, Ouyang QC, Zheng QF, Yuan ZY, Chen DS, Jiang KK, Lin Y, Dai Z, Liu XL, Chen QJ, Wu XH, Shi YX, Huang JJ, An X, Xue C, Bi XW, Chen MT, Li H, Yao HR, Zou GR, Huang H, Zhang JM, Wang SS. Hong RX, et al. Among authors: an x. J Clin Oncol. 2025 Jan 2:JCO2400938. doi: 10.1200/JCO.24.00938. Online ahead of print. J Clin Oncol. 2025. PMID: 39746176
3,039 results